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Structural and biophysical characterisation of membrane protein–ligand bindingA detailed understanding of membrane protein structure and func-
tion remains of profound importance on many fronts, not least of
which includes drug discovery. In a post-genomic era it is now well
established that a sizeable 20–30% of eukaryotic, eubacterial and ar-
chaean open reading frames encode integral membrane proteins. Fur-
thermore, membrane proteins constitute approximately 49% of
current therapeutic targets in higher organisms, providing evidence of
their strong potential as targets for new drugs of the future. A detailed
understanding of how agonist and antagonist ligands interact and
bindwith membrane protein drug targets is important for the develop-
ment and reﬁnement of new and novel therapeutics. Although
commercially-available drugs targeting membrane proteins have so
far been generated mainly through conventional means (high through-
put screening, functional assays etc.), the availability of structure-based
and/or biophysical techniques for investigating membrane protein–
ligand interactions reveals the details of how ligands and potential
new drugs bind. The purpose of this Special Issue is to provide a review
of some biophysical techniques available for studying membrane pro-
tein interactions with ligands and drugs. It also reviews some of the lat-
est developments in methods and approaches for structure elucidation,
particularly focusing on optimisation of membrane protein crystal
growth for structure determination using X-ray crystallography, one
of the pre-requisites for structure-based investigations of ligand bind-
ing. Utilisation of the important techniques of solid- and solution-state
NMR for structural studies of membrane proteins has already been de-
scribed recently in another Special Issue in this journal, and therefore
the technique has not been included here; the reader is therefore re-
ferred to the BBA Biomembranes Special Issue ‘NMR Structural Studies
on Membrane Proteins’ 1768 (2007) issue 12.
In the lead article, Dr. Richard Ward and Professor Graeme Milligan
describe how resonance energy transfer and ﬂuorescent labelling tech-
niques have been applied to ligand identiﬁcation and binding studies of
G protein-coupled receptors (GPCRs). They also describe how the iden-
tiﬁcation of GPCR ligands using these techniques has aided progress in
structural determinations of these proteins, as successful crystal trials
have usually been performed in the presence of receptor ligands to pro-
mote receptor stabilisation. A description of how widely ﬂuorescence
spectroscopy techniques have been used for studies of GPCR proteins
is presented by Dr. Rajashri Sridharan and colleagues. They present an
overview of the extensive array of ﬂuorescent ligands that have previ-
ously been developed and how studies with such ligands have contrib-
uted to our understanding of the diversity of receptor conformations
adopted through binding by different ligands. The use of circular dichro-
ism (CD) spectroscopy for investigating membrane protein–ligand
interactions, and the particular advantages of using synchrotron radia-
tion CD for studies of puriﬁed membrane proteins available in only lim-
ited supplies are aspects addressed in the chapter by Dr. Giuliano0005-2736/$ – see front matter © 2013 Elsevier B.V. All rights reserved.
http://dx.doi.org/10.1016/j.bbamem.2013.09.013Siligardi, Dr. Rohanah Hussain and colleagues. Use of synchrotron radia-
tion to generate CD spectra has enabled increased accuracy in secondary
structural information due to the extended spectral range that can be re-
liably acquired in the far-UV region. Also described is the recent collabo-
rative work between my own laboratory and the Diamond Light Source,
which demonstrated for the ﬁrst time the suitability of CD spectroscopy
for obtaining quantitative binding data for ligand binding to amembrane
protein, in this case a bacterial membrane histidine protein kinase. This
work also revealed the conditions necessary for ensuring the stability
of puriﬁed proteins prior to obtaining spectra and therefore this sensitive
technique has subsequently proved useful in structural determination
efforts as a screening technique to monitor sample stability prior to
crystallisation trials. Dr. Simon Patching discusses surface plasmon reso-
nance (SPR) spectroscopy, a rapidly developing technique in the ﬁeld of
membrane protein–ligand interactions. A wide range of protein exam-
ples are described, including representatives from several protein fami-
lies, and including GPCRs, a range of human and bacterial receptors, an
ABC transporter and α-haemolysin. The chapter also focuses on the po-
tential of the method for future drug discovery. Dr. Allison Whited and
Professor Paul Park discuss atomic force microscopy (AFM), including
the basic principles of the technique and how it has evolved for
visualising single membrane protein–ligand complexes and conforma-
tional changes elicited through ligand binding. They also describe how
AFM can be used to characterise interactions through dissociation of
membrane protein–ligand complexes by force. The well-established
technique of isothermal titration calorimetry (ITC) is described in detail
by Professor Krishna Rajarathnam and Dr. Jörg Rösgen. Its application
for studies of membrane protein–ligand interactions is emerging;
fewer examples ofmembrane protein–ligand studies are currently avail-
able. However, the authors provide a comprehensive description of con-
ditions that have proved successful so far in ITC studies of membrane
proteins. They describe the effects of detergent choice and consider-
ations of protein/ligand concentrations that have proved successful dur-
ing ITCmeasurements. They go on to describe several examples of ligand
binding studies involving mammalian proteins, including chemokine
binding to the human GPCR CCR5 and agonist and antagonist binding
to a human ion channel, as well as a host of bacterial examples. Finally,
Dr. Isabel Moraes and colleagues discuss structure determination, focus-
ing particularly on recent developments in methods and strategies for
membrane protein crystal production (including choice of detergents,
rational design of crystallisation screens based on knowledge of mem-
brane proteins already successfully crystallised and use of crystal dehy-
dration techniques). They also describe ways in which synchrotron
radiation and free electron lasers have recently been applied to enable
data collection from small fragile crystals of membrane proteins.
A striking feature that emerges from many of these articles in this
Special Issue is the rapidity with which new applications of some
2 Prefacwell-established biophysical techniques are emerging for investigations
of membrane proteins. Not only are these advances occurring at a
rapid rate, but some provide the possibility of improved or modiﬁed
approaches for structure determination, for example, by identifying
improved conditions for promoting successful growth of protein
crystals. In turn, of course, the reverse is also true; it is well established
that structural details at atomic resolution provide a valuable source
of data for detailed ligand binding studies. What is clear is how inter-
linked and inter-reliant the structural and biophysical methodologies
are for progress; it seems clear that future advances in the ﬁeld of
membrane proteins are served well by continued utilisation and
progress in all the techniques described in this Special Issue—and others
too. These approaches go hand in hand, and the future looks rosy.
My thanks to all the contributing authors of this Special Issue for
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